Patient Guide: A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 14 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07099898
Status: 🟢 Enrolling Now
Condition: Neoplasms, Lung
Phase: PHASE3

Where You Can Participate

This study is available at 14 locations across the country.

Top locations include:
  • • Buenos Aires,
  • • Ciudad Autonoma de Buenos Aire,
  • • Ciudad Autonoma de Buenos Aire,
  • • And 11 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) - Join Clinical Trial NCTNCT07099898

How to Join This Clinical Trial - NCTNCT07099898

Learn how to participate in this PHASE3 trial studying an investigational therapy for Neoplasms, Lung. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Neoplasms, Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Neoplasms, Lung
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07099898 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 14 locations. Find a study site near you:

Clinical Research Site

Buenos Aires, C1426ABP - Argentina

Status: RECRUITING

Clinical Research Site

Ciudad Autonoma de Buenos Aire, C1012AAR - Argentina

Status: RECRUITING

Clinical Research Site

Ciudad Autonoma de Buenos Aire, C1426AGE - Argentina

Status: RECRUITING

Clinical Research Site

Rosario, S2000 DEJ - Argentina

Status: RECRUITING

Clinical Research Site

Blacktown, New South Wales 2148 - Australia

Status: RECRUITING

Clinical Research Site

St Leonards, New South Wales 2065 - Australia

Status: RECRUITING

Clinical Research Site

Nedlands, Western Australia 6009 - Australia

Status: RECRUITING

Clinical Research Site

Ottawa, Ontario K1H 8L6 - Canada

Status: RECRUITING

Clinical Research Site

Fukuoka, 812-8582 - Japan

Status: RECRUITING

Clinical Research Site

Osaka, 594-0073 - Japan

Status: RECRUITING

And 4 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Neoplasms, Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships